Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fatima McKenzie, Devin Cash, Angela Gupta, Laurel W. Cummings & Alex G. Ortega-Loayza. (2019) Biologic and small-molecule medications in the management of pyoderma gangrenosum. Journal of Dermatological Treatment 30:3, pages 264-276.
Read now
Read now
Sirichai Pasadhika & James T Rosenbaum. (2014) Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics: Targets and Therapy 8, pages 67-81.
Read now
Read now
M Cottone & V Criscuoli. (2011) Infliximab to treat Crohn’s disease: an update. Clinical and Experimental Gastroenterology 4, pages 227-238.
Read now
Read now
Articles from other publishers (52)
Hannah Gordon, Johan Burisch, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Mariangela Allocca, Giorgos Bamias, Manuel Barreiro-de Acosta, Tasanee Braithwaite, Thomas Greuter, Catherine Harwood, Pascal Juillerat, Triana Lobaton, Ulf Müller-Ladner, Nurulamin Noor, Gianluca Pellino, Edoardo Savarino, Christoph Schramm, Alessandra Soriano, Jürgen Michael Stein, Mathieu Uzzan, Patrick F van Rheenen, Stephan R Vavricka, Maurizio Vecchi, Stephane Zuily & Torsten Kucharzik. (2023) ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's and Colitis.
Crossref
Crossref
Xue Wu, Mengying Tao, Ling Zhu, Ting Zhang & Ming Zhang. (2022) Pathogenesis and current therapies for non-infectious uveitis. Clinical and Experimental Medicine 23:4, pages 1089-1106.
Crossref
Crossref
Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro-Iglesias, Tom Holvoet, Yamile Zabana, Laia Peries Reverter, Gerard Bryan Gonzales, Jeroen Geldof, Gaëlle Varkas, Martine De Vos & Triana Lobatón. (2022) The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study. Journal of Crohn's and Colitis 16:11, pages 1676-1686.
Crossref
Crossref
Shaina Sekhri, Bharat Rao, Akanksha Mohananey, Poonam Beniwal-Patel, Alexandra Bruss, Daniel J Stein & Andres J Yarur. (2021) Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease. BMJ Open Gastroenterology 8:1, pages e000788.
Crossref
Crossref
Thomas Greuter, Florian Rieder, Torsten Kucharzik, Laurent Peyrin-Biroulet, Alain M Schoepfer, David T Rubin & Stephan R Vavricka. (2021) Emerging treatment options for extraintestinal manifestations in IBD. Gut 70:4, pages 796-802.
Crossref
Crossref
Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath & Brian G. Feagan. (2021) Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 81:3, pages 333-347.
Crossref
Crossref
Lucas Guillo, Ferdinando D’Amico, Mélanie Serrero, Karine Angioi, Damien Loeuille, Antonio Costanzo, Silvio Danese & Laurent Peyrin‐Biroulet. (2020) Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterology Journal 8:9, pages 1013-1030.
Crossref
Crossref
Rohan Bir Singh, Shruti Sinha, Chhavi Saini, Elsayed Elbasiony, Sahil Thakur & Aniruddha Agarwal. (2020) Recent advances in the management of non-infectious posterior uveitis. International Ophthalmology 40:11, pages 3187-3207.
Crossref
Crossref
Akshay S. Thomas. (2019) Biologics for the treatment of noninfectious uveitis. Current Opinion in Ophthalmology 30:3, pages 138-150.
Crossref
Crossref
Hakim Ben Abdallah, Karsten Fogh & Rikke Bech. (2019) Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi‐systematic review. International Wound Journal 16:2, pages 511-521.
Crossref
Crossref
Laura J. Kopplin & Amde Selassie Shifera. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
67
84
.
Rebecca Faleiro, Ji Liu, Deshapriya Karunarathne, Aleksandra Edmundson, Clay Winterford, Tam Hong Nguyen, Lisa A Simms, Graham Radford‐Smith & Michelle Wykes. (2019) Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cells. Clinical & Translational Immunology 8:7.
Crossref
Crossref
Gerard Espinosa, Santiago Muñoz-Fernández, José M. García Ruiz de Morales, José M. Herreras & Miguel Cordero-Coma. (2017) Documento de recomendaciones de tratamiento de la uveítis anterior no infecciosa. Medicina Clínica 149:12, pages 552.e1-552.e12.
Crossref
Crossref
Gerard Espinosa, Santiago Muñoz-Fernández, José M. García Ruiz de Morales, José M. Herreras & Miguel Cordero-Coma. (2017) Document of treatment recommendations for non-infectious anterior uveitis. Medicina Clínica (English Edition) 149:12, pages 552.e1-552.e12.
Crossref
Crossref
Thomas Greuter, Alexander Navarini & Stephan R. Vavricka. (2017) Skin Manifestations of Inflammatory Bowel Disease. Clinical Reviews in Allergy & Immunology 53:3, pages 413-427.
Crossref
Crossref
Thomas Greuter, Fabio Bertoldo, Roman Rechner, Alex Straumann, Luc Biedermann, Jonas Zeitz, Benjamin Misselwitz, Michael Scharl, Gerhard Rogler, Ekaterina Safroneeva, Raja A.R. Ali, Christian Braegger, Klaas Heyland, Pascal Mueller, Andreas Nydegger, Laetitia-Marie Petit, Susanne Schibli, Raoul I. Furlano, Johannes Spalinger, Michela Schäppi, Samuel Zamora, Florian Froehlich, Denise Herzog, Alain M. Schoepfer & Stephan R. Vavricka. (2017) Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment. Journal of Pediatric Gastroenterology & Nutrition 65:2, pages 200-206.
Crossref
Crossref
Stephan R. Vavricka, Martin Gubler, Claudine Gantenbein, Muriel Spoerri, Florian Froehlich, Frank Seibold, Marijana Protic, Pierre Michetti, Alex Straumann, Nicolas Fournier, Pascal Juillerat, Luc Biedermann, Jonas Zeitz, Benjamin Misselwitz, Michael Scharl, Henriette Heinrich, Christine N. Manser, Ekaterina Safroneeva, Raja Affendi Raja Ali, Gerhard Rogler, Alain M. Schoepfer & Thomas Greuter. (2017) Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflammatory Bowel Diseases 23:7, pages 1174-1181.
Crossref
Crossref
Leandro Lopes Troncoso, Ana Luiza Biancardi, Haroldo Vieira de Moraes Jr & Cyrla Zaltman. (2017) Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World Journal of Gastroenterology 23:32, pages 5836.
Crossref
Crossref
Laurent Peyrin-Biroulet, Gert Van Assche, David Gómez-Ulloa, Laura García-Álvarez, Núria Lara, Chris M. Black & Sumesh Kachroo. (2017) Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 15:1, pages 25-36.e27.
Crossref
Crossref
Rosario Peluso, Francesco Manguso, Maria Vitiello, Salvatore Iervolino & Matteo Nicola Dario Di Minno. (2014) Management of arthropathy in inflammatory bowel diseases. Therapeutic Advances in Chronic Disease 6:2, pages 65-77.
Crossref
Crossref
Tejas Sheth, C. S. Pitchumoni & Kiron M. Das. (2015) Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease. Gastroenterology Research and Practice 2015, pages 1-11.
Crossref
Crossref
Laura J. Kopplin, Amde S. Shifera, Eric B. Suhler & Phoebe Lin. (2015) Biological Response Modifiers in the Treatment of Noninfectious Uveitis. International Ophthalmology Clinics 55:2, pages 19-36.
Crossref
Crossref
Ignazio Olivieri, Fabrizio Cantini, Fabiana Castiglione, Carla Felice, Paolo Gionchetti, Ambrogio Orlando, Carlo Salvarani, Raffaele Scarpa, Maurizio Vecchi & Alessandro Armuzzi. (2014) Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmunity Reviews 13:8, pages 822-830.
Crossref
Crossref
Virendra N. Sehgal, Deepika Pandhi & Ananta Khurana. (2014) Nonspecific genital ulcers. Clinics in Dermatology 32:2, pages 259-274.
Crossref
Crossref
Luisa Costa, Mariangela Atteno, Francesco Caso, Luigi Scarpato, Antonio Del Puente & Raffaele Scarpa. (2014) Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept. International Journal of Rheumatic Diseases 17:2, pages 219-220.
Crossref
Crossref
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés & Fernando Gomollón. (2013) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013). Gastroenterología y Hepatología 36:3, pages 127-146.
Crossref
Crossref
Antonio Di Sabatino, Lucio Liberato, Monia Marchetti, Paolo Biancheri & Gino R. Corazza. (2011) Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease. Internal and Emergency Medicine 6:S1, pages 17-27.
Crossref
Crossref
Tina A. Mehta & Chris S. J. Probert. 2011. Clinical Dilemmas in Inflammatory Bowel Disease. Clinical Dilemmas in Inflammatory Bowel Disease
129
132
.
Mary Pham, Clement C. Chow, David Badawi & Elmer Y. Tu. (2011) Use of Infliximab in the Treatment of Peripheral Ulcerative Keratitis in Crohn Disease. American Journal of Ophthalmology 152:2, pages 183-188.e2.
Crossref
Crossref
Karine Angioi, Pierre Kaminsky & Laurent Peyrin-Biroulet. (2011) Infliximab for severe peripheral ulcerative keratopathy revealing Crohnʼs disease. Inflammatory Bowel Diseases 17:3, pages 866-867.
Crossref
Crossref
Lianne K.P.M. Brakenhoff, Désirée M. van der Heijde, Daniel W. Hommes, Tom W.J. Huizinga & Herma H. Fidder. (2010) The joint–gut axis in inflammatory bowel diseases. Journal of Crohn's and Colitis 4:3, pages 257-268.
Crossref
Crossref
Rogelio A. CoronadoCharles Z. SheetsChad E. CookWilliam G. Boissonnault. (2010) Spondyloarthritis in a Patient With Unilateral Buttock Pain and History of Crohn Disease. Physical Therapy 90:5, pages 784-792.
Crossref
Crossref
Jeremiah Miller, Brad A. Yentzer, Adele Clark, Joseph L. Jorizzo & Steven R. Feldman. (2010) Pyoderma gangrenosum: A review and update on new therapies. Journal of the American Academy of Dermatology 62:4, pages 646-654.
Crossref
Crossref
Antonio Rispo, Anna Testa, Maria Diaferia, Fabiana Castiglione & Maurizio Lo Presti. (2009) Monster parastomal pyoderma gangrenosum effectively treated by topical tacrolimus. Journal of Crohn's and Colitis 3:3, pages 218-219.
Crossref
Crossref
Antonio Rispo, Raffaele Scarpa, Maria Diaferia, Anna Testa & Fabiana Castiglione. (2008) Lack of efficacy of azathioprine in the treatment of axial arthritis complicating Crohn's disease. Journal of Crohn's and Colitis 2:4, pages 357-358.
Crossref
Crossref
I Palamaras, J El-Jabbour, N Pietropaolo, P Thomson, S Mann, W Robles & HP Stevens. (2008) Metastatic Crohn's disease: a review. Journal of the European Academy of Dermatology and Venereology 22:9, pages 1033-1043.
Crossref
Crossref
. (2008) Treatment of Recurrent Crohn's Uveitis With Infliximab. The American Journal of Gastroenterology 103:8, pages 2150-2151.
Crossref
Crossref
S. Nikolaus & S. Schreiber. (2008) Anti-TNF-Biologika in der Therapie chronisch-entzündlicher DarmerkrankungenAnti-TNF biologics in the treatment of chronic inflammatory bowel disease. Der Internist 49:8, pages 947-954.
Crossref
Crossref
. (2008) Treatment of Recurrent Crohn's Uveitis With Infliximab. The American Journal of Gastroenterology, pages ???-???.
Crossref
Crossref
Jan Lin, David Ziring, Sheetal Desai, Sungjin Kim, Maida Wong, Yael Korin, Jonathan Braun, Elaine Reed, David Gjertson & Ram Raj Singh. (2008) TNFα blockade in human diseases: An overview of efficacy and safety. Clinical Immunology 126:1, pages 13-30.
Crossref
Crossref
Robert D. Inman. 2008. Primer on the Rheumatic Diseases. Primer on the Rheumatic Diseases
217
223
.
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Primera parte: infliximab y adalimumab. Actas Dermo-Sifiliográficas 98:10, pages 657-678.
Crossref
Crossref
Ulrich Mrowietz, James T. Elder & Jonathan Barker. (2006) The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Archives of Dermatological Research 298:7, pages 309-319.
Crossref
Crossref
Jeffrey P. Callen & J. Mark Jackson. (2007) Pyoderma Gangrenosum: An Update. Rheumatic Disease Clinics of North America 33:4, pages 787-802.
Crossref
Crossref
Heidemarie Becker, Markus Gaubitz, Wolfram Domschke & Torsten Kucharzik. (2007) Treatment of arthralgias and spondyloarthropathy associated with inflammatory bowel disease. Future Rheumatology 2:4, pages 423-431.
Crossref
Crossref
PANAGIOTIS G. THEODOSSIADIS, NIKOLAOS N. MARKOMICHELAKIS & PETROS P. SFIKAKIS. (2007) TUMOR NECROSIS FACTOR ANTAGONISTS. Retina 27:4, pages 399-413.
Crossref
Crossref
Ziad Reguia??Florent Grange. (2007) The Role of Anti-Tumor Necrosis Factor-?? Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease. American Journal of Clinical Dermatology 8:2, pages 67-77.
Crossref
Crossref
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 1: Infliximab and Adalimumab. Actas Dermo-Sifiliográficas (English Edition) 98:10, pages 657-678.
Crossref
Crossref
Philippe Eloy, E. Leruth, Y. Goffart, M. C. Nollevaux, V. Fridman, M. Dartevelle, M. Melange, J. Daele & B. Bertrand. (2006) Sinonasal involvement as a rare extraintestinal manifestation of Crohn’s disease. European Archives of Oto-Rhino-Laryngology 264:1, pages 103-108.
Crossref
Crossref
Mary Jo. J. Kerns, Julia E. Graves, David I. Smith & Michael P. Heffernan. (2006) Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update. Seminars in Cutaneous Medicine and Surgery 25:4, pages 226-240.
Crossref
Crossref
Arthur Barrie & Scott Plevy. (2006) Treatment of Immune-Mediated Extraintestinal Manifestations of Inflammatory Bowel Disease with Infliximab. Gastroenterology Clinics of North America 35:4, pages 883-893.
Crossref
Crossref
G.R. Lichtenstein. (2006) Infliximab in the Treatment of Extra-Intestinal Manifestations of Crohn's Disease. Yearbook of Gastroenterology 2006, pages 128-129.
Crossref
Crossref